• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

唑来膦酸治疗多发性骨髓瘤晚期溶骨性病变导致危及生命的低磷血症。

Life-threatening hypophosphataemia secondary to zoledronic acid implementation in a middle-age patient who presented with advanced osteolysis in the course of multiple myeloma.

机构信息

Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.

2nd Department of Clinical Radiology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.

出版信息

Endokrynol Pol. 2020;71(1):100-101. doi: 10.5603/EP.a2019.0048. Epub 2019 Nov 4.

DOI:10.5603/EP.a2019.0048
PMID:31681977
Abstract

Not required for Clinical Vignette.

摘要

临床病例中不需要。

相似文献

1
Life-threatening hypophosphataemia secondary to zoledronic acid implementation in a middle-age patient who presented with advanced osteolysis in the course of multiple myeloma.唑来膦酸治疗多发性骨髓瘤晚期溶骨性病变导致危及生命的低磷血症。
Endokrynol Pol. 2020;71(1):100-101. doi: 10.5603/EP.a2019.0048. Epub 2019 Nov 4.
2
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma.唑来膦酸诱发的多发性骨髓瘤患者眼眶炎症
J Oncol Pharm Pract. 2019 Jul;25(5):1253-1257. doi: 10.1177/1078155218785967. Epub 2018 Jul 13.
3
Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis.一名AL淀粉样变性患者接受唑来膦酸治疗后出现低钙血症和低磷血症。
Intern Emerg Med. 2019 Apr;14(3):447-449. doi: 10.1007/s11739-019-02048-w. Epub 2019 Feb 15.
4
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.地舒单抗对比唑来膦酸在初诊多发性骨髓瘤骨病治疗中的应用：一项国际性、双盲、双模拟、随机、对照、3 期研究。
Lancet Oncol. 2018 Mar;19(3):370-381. doi: 10.1016/S1470-2045(18)30072-X. Epub 2018 Feb 9.
5
Symptomatic hypocalcemia following a single dose of zoledronic acid in a patient with bone metastases secondary to breast cancer.乳腺癌骨转移患者单次使用唑来膦酸后出现症状性低钙血症。
J Oncol Pharm Pract. 2021 Mar;27(2):494-497. doi: 10.1177/1078155220940411. Epub 2020 Jul 13.
6
Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.唑来膦酸诱发骨质疏松症患者低钙血症和低磷血症：一个值得关注的问题。
Curr Drug Saf. 2016;11(3):267-9. doi: 10.2174/1574886311666160426141647.
7
Management of multiple myeloma bone disease: impact of treatment on renal function.多发性骨髓瘤骨病的治疗管理：治疗对肾功能的影响。
Expert Rev Hematol. 2018 Nov;11(11):881-888. doi: 10.1080/17474086.2018.1531702. Epub 2018 Oct 20.
8
Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction.静脉注射铁剂和地诺单抗后出现严重低钙血症和低磷血症：一种新型药物相互作用。
Intern Med J. 2016 Mar;46(3):360-3. doi: 10.1111/imj.13001.
9
Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients with Multiple Myeloma: Results of the Z-MARK Study.骨标志物指导下唑来膦酸给药预防多发性骨髓瘤患者骨骼并发症：Z-MARK研究结果
Clin Cancer Res. 2016 Mar 15;22(6):1378-84. doi: 10.1158/1078-0432.CCR-15-1864. Epub 2015 Dec 7.
10
Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma.两例多发性骨髓瘤患者出现严重低磷血症和孤立性高磷尿症。
Am J Kidney Dis. 1997 Mar;29(3):445-8. doi: 10.1016/s0272-6386(97)90207-9.